ellacor from Cytrellis Cleared for Moderate-to-Severe Facial Wrinkles

FDA has cleared the ellacor system from Cytrellis for the treatment of moderate-to-severe wrinkles in the mid to lower face. The minimally invasive device, featuring Micro-Coring technology, is a first-in-category device that safely removes micro-sized portions of excess skin without surgery, thermal energy, or evidence of scarring.

"We are thrilled to receive this FDA clearance for our Micro-Coring technology. It is a result of our team's extensive research and collaboration with leading physicians in the aesthetics industry. We have developed a truly innovative device," says Karen Cronholm, President and CEO of Cytrellis. "Ellacor is a simple, yet more effective procedure that provides patients and physicians with what they have been asking for - natural looking results."

Based on the initial research of Cytrellis’ scientific founders, Dr. William Austen, Jr. and Dr. Rox Anderson, the novel system mechanically removes full-thickness cores of skin. "It can remove as much skin as some surgical procedures without scarring," says William G. Austen, Jr. MD, Chief of Plastic and Reconstructive Surgery, Chief of Burn Surgery at MGH in Boston and Professor of Surgery at Harvard Medical School. 

Jill S. Waibel, MD explains more about this procedure in an article in Practical Dermatology®.